Sophia Randolph

CIK 1817127 · CHIEF MEDICAL OFFICER · last filed 2024-08-16

Sophia Randolph is a CHIEF MEDICAL OFFICER who has filed 24 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $3.5K of ALXO on Aug 16, 2024. Across all open-market trades the lifetime net is −$4.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $648.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$648.2K

Companies

1

Total Filings

24

Lifetime Open-Market Net

-$4.64M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALXO CHIEF MEDICAL OFFICER 325,711 $1.99 $648.2K -$4.64M 23 2024-08-16

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-08-16 ALXO Sell (S) −1,365 -$3.5K EDGAR
2024-07-03 ALXO Sell (S) −3,273 -$19.0K EDGAR
2024-05-15 ALXO Sell (S) −12,000 -$191.3K EDGAR
2024-05-13 ALXO Notice (144) −78,000 -$1.26M EDGAR
2024-02-16 ALXO Grant (A) +30,000 $0 EDGAR
2024-01-03 ALXO Sell (S) −3,128 -$47.0K EDGAR
2023-07-27 ALXO Grant (A) +34,000 $0 EDGAR
2023-07-05 ALXO Sell (S) −1,605 -$11.8K EDGAR
2023-06-13 ALXO Exer (M) +12,829 $48.2K EDGAR
2023-01-03 ALXO Sell (S) −1,617 -$17.9K EDGAR
Showing 110 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.